Interview with Melvin Oscar D’souza, Managing Director, Novo Nordisk India Private Limited
27.07.2012
Related Interviews
Peter DeYoung – CEO, Global Pharma, Piramal Pharma Limited
Peter DeYoung shares the significance of Indian giant Piramal Pharma’s recent demerger from its parent company and its current strategic focus on organic growth, brownfield expansions, and “complex hospital generics.”…
Sudarshan Jain – Secretary General, Indian Pharmaceutical Alliance (IPA)
As secretary general of the Indian Pharmaceutical Alliance (IPA) Sudarshan Jain represents the interests of 25 leading Indian pharmaceutical companies, both at home and abroad. He outlines the association’s focus…
Daara Patel – Secretary General, Indian Drug Manufacturers’ Association…
The IDMA’s Daara Patel outlines the association’s role in representing the diverse voices of the Indian pharmaceutical sector, advocating for manufacturers of all sizes. He explores the challenges and initiatives…
Long Read / Moroccan Healthcare Reform: Lofty Ambitions, Universal Benefits
Morocco is currently implementing the most ambitious, far-reaching, and comprehensive health system reorganizations in its history. “What sets this reform apart from all that has happened before is just how…
Portugal / Medical Cannabis Exports Up 63%, On Track to Become a Key Global Player
Portugal’s strong legal framework along with its low production costs and strategic location within Europe have given rise to a thriving medicinal cannabis sector. With exports in 2022 that surpassed…
UK / 5 HTA Trends to Watch from NICE Chief Executive Samantha Roberts
Since its creation over 20 years ago, the National Institute for Health and Care Excellence (NICE), the Health Technology Assessment (HTA) body for England and Wales, has forged a solid…
